RxDoctor Payments Data

Jeremiah Jeffers, MD

Pain Medicine · Bayamon, PRNPI 1497041537

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $905 of the $1,035 with a category attached, or 87.5%. 9 manufacturers reported payments, led by Nevro Corp. at 33.6% of the total. Reporting peaked in 2023 at $434 and has fallen 54.4% since, to $198 in 2025.

$1,035in general payments, 2019–2025

Across 20 payments — averaging $51.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$348
  • Medtronic$280
  • Boston Scientific$138
  • Hologic Sales And Service, LLC$75
  • SPR Therapeutics, Inc$53
  • Roche Diagnostics Corporation$45
  • plus $96 from 3 others

What the payments were for

  • Travel & lodging$13013%
  • Food & beverage$90587%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,035 in reported general payments places this provider in the 70th percentile of 46 pain medicine providers in Puerto Rico.

See all pain medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$16,660
Medicare patients
25
Services billed
956

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Potassium34$1,494
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen36$636
Pregabalin13$529
Diclofenac Sodium16$298
Meloxicam37$231
Gabapentin23$224
Duloxetine Hcl23$217
Tizanidine Hcl16$96

Paid to pharmacies, not to this prescriber.

Other pain medicine in Bayamon

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →